
Tafinlar (Dabrafenib)
TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved…
TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved…
TAGRISSO is a kinase inhibitor indicated for: as adjuvant therapy after tumor resection in adult patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth…
Helps prevent dental caries and hypersensitivity. ACTIVE INGREDIENT: Sodium Fluoride 1.1% (0.5% Fluoride Ion). OTHER INGREDIENTS. Purified water, glycerin. Xylitol and other sweeteners. Contains FD&C Blue #1. DIRECTIONS. Adults and children six…
TAKHZYRO(TM) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years and older. TAKHZYRO is a plasma kallikrein inhibitor (monoclonal antibody)…
TALICIA is a three-drug combination of omeprazole, a proton pump inhibitor, amoxicillin, a penicillin-class antibacterial, and rifabutin, a rifamycin antibacterial, indicated for the…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2021. All Rights Reserved.